Home      The Academy      Mission Statement      Meetings      EATI Members      Links

Laurence Zitvogel, M.D., Ph.D.


Email:
zitvogel(a)igr.fr

Institution:
Institut GustaveRoussy

Bio:
Dr. Laurence Zitvogel is the Research Director at Institut National de la Santé et Recherche Médicale in a laboratory located at Institut GrustaveRoussy, Villejuif, France. She graduated in 1992 with a degree in Medical Oncology from the School of Medicine of the University of Paris, France. She began her scientific career at the University of Pittsburgh, USA working under Michael Lotze. Her expertise is mainly dendritic cell and innate effector biology and relevance during tumor development, as well as exosome-based vaccine designs.

Abstracts:
Jul 1, 2012 Trial Watch: Immunostimulatory cytokines.
Jul 1, 2012 Abscopal but desirable: The contribution of immune responses to the efficacy ofradiotherapy.
Jun 25, 2012 Immunoregulatory Natural Killer Cells Suppress Autoimmunity by Down-Regulating Antigen-Specific CD8+ T Cells in Mice.
May 1, 2012 Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer
May 1, 2012 Trial Watch: Adoptive cell transfer immunotherapy
May 1, 2012 Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
May 1, 2012 Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
May 1, 2012 Subversion of the chemotherapy-induced anticancer immune response by theecto-ATPase CD39.
May 1, 2012 Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
May 1, 2012 Trial Watch: Adoptive cell transfer immunotherapy.
May 1, 2012 Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response tochemotherapy in non-small cell lung cancer.
Mar 18, 2012 Inflammasomes in carcinogenesis and anticancer immune responses.
Mar 16, 2012 Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.
Mar 6, 2012 Reply to: Chemotherapy response of spontaneous mammary tumors is independent ofthe adaptive immune system.
Mar 1, 2012 The European Academy of Tumor Immunology: Bridging fields, continents andgenerations.
Feb 15, 2012 Recent successes of cancer immunotherapy: a new dimension in personalizedmedicine?
Jan 1, 2012 OncoImmunology: a new journal at the frontier between oncology and immunology
Jan 1, 2012 The fabulous legacy of a Nobel Prize Laureate: Ralph M. Steinman, 1943-2011
Jan 1, 2012 Trial Watch: Monoclonal antibodies in cancer therapy
Jan 1, 2012 Trial Watch: Monoclonal antibodies in cancer therapy.
Jan 1, 2012 OncoImmunology: a new journal at the frontier between oncology and immunology.
Dec 22, 2011 Antibody co-targeting of DCs.
Dec 16, 2011 Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.
Dec 14, 2011 Defining the Critical Hurdles in Cancer Immunotherapy.

Your are accessing the site from: 54.205.179.23